{"id":"https://openalex.org/W4298395295","doi":"https://doi.org/10.1093/neuonc/noac200.072","title":"Improving the Odds - Long Term Survivors of Glioblastoma Multiforme (GBM)","display_name":"Improving the Odds - Long Term Survivors of Glioblastoma Multiforme (GBM)","publication_year":2022,"publication_date":"2022-10-01","ids":{"openalex":"https://openalex.org/W4298395295","doi":"https://doi.org/10.1093/neuonc/noac200.072"},"language":"en","primary_location":{"id":"doi:10.1093/neuonc/noac200.072","doi":"https://doi.org/10.1093/neuonc/noac200.072","is_oa":true,"landing_page_url":"https://doi.org/10.1093/neuonc/noac200.072","pdf_url":"https://academic.oup.com/neuro-oncology/article-pdf/24/Supplement_4/iv16/46175993/noac200.072.pdf","source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://academic.oup.com/neuro-oncology/article-pdf/24/Supplement_4/iv16/46175993/noac200.072.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026841937","display_name":"Palwasha Khan Akbar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800860831","display_name":"NHS Tayside","ror":"https://ror.org/000ywep40","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800860831"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Palwasha Khan Akbar","raw_affiliation_strings":["NHS Tayside"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NHS Tayside","institution_ids":["https://openalex.org/I2800860831"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5026106397","display_name":"Hannah Lord","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800860831","display_name":"NHS Tayside","ror":"https://ror.org/000ywep40","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800860831"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Hannah Lord","raw_affiliation_strings":["NHS Tayside"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NHS Tayside","institution_ids":["https://openalex.org/I2800860831"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I2800860831"],"apc_list":{"value":4612,"currency":"USD","value_usd":4612},"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"24","issue":"Supplement_4","first_page":"iv16","last_page":"iv16"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10178","display_name":"Cancer survivorship and care","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":1.0},{"id":"https://openalex.org/keywords/long-term-survival","display_name":"long-term survival","score":0.9860000014305115},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.8610000014305115},{"id":"https://openalex.org/keywords/mgmt-promoter-methylation","display_name":"MGMT promoter methylation","score":0.9279999732971191},{"id":"https://openalex.org/keywords/idh1-mutation","display_name":"IDH1 mutation","score":0.996999979019165},{"id":"https://openalex.org/keywords/chemoradiotherapy","display_name":"chemoradiotherapy","score":0.9359999895095825},{"id":"https://openalex.org/keywords/adjuvant-chemotherapy","display_name":"adjuvant chemotherapy","score":0.9980000257492065},{"id":"https://openalex.org/keywords/radiotherapy-dose","display_name":"radiotherapy dose","score":0.6700000166893005},{"id":"https://openalex.org/keywords/age-at-diagnosis","display_name":"age at diagnosis","score":0.628000020980835},{"id":"https://openalex.org/keywords/disease-progression","display_name":"disease progression","score":0.5220000147819519}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8676728010177612},{"id":"https://openalex.org/C127848430","wikidata":"https://www.wikidata.org/wiki/Q18027543","display_name":"IDH1","level":4,"score":0.6107491254806519},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5752108097076416},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.552836537361145},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.5460725426673889},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5118576884269714},{"id":"https://openalex.org/C2776194525","wikidata":"https://www.wikidata.org/wiki/Q282142","display_name":"Glioblastoma","level":2,"score":0.5057001113891602},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5049110054969788},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.45808330178260803},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.44458550214767456},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3707674741744995},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.14733722805976868},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.07620131969451904},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1093/neuonc/noac200.072","doi":"https://doi.org/10.1093/neuonc/noac200.072","is_oa":true,"landing_page_url":"https://doi.org/10.1093/neuonc/noac200.072","pdf_url":"https://academic.oup.com/neuro-oncology/article-pdf/24/Supplement_4/iv16/46175993/noac200.072.pdf","source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9525852","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9525852","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro Oncol","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1093/neuonc/noac200.072","doi":"https://doi.org/10.1093/neuonc/noac200.072","is_oa":true,"landing_page_url":"https://doi.org/10.1093/neuonc/noac200.072","pdf_url":"https://academic.oup.com/neuro-oncology/article-pdf/24/Supplement_4/iv16/46175993/noac200.072.pdf","source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4298395295.pdf","grobid_xml":"https://content.openalex.org/works/W4298395295.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4416141330","https://openalex.org/W3205448162","https://openalex.org/W4400273283","https://openalex.org/W3112146477","https://openalex.org/W2852589091","https://openalex.org/W7167592536","https://openalex.org/W4389446933","https://openalex.org/W2622584877","https://openalex.org/W4389447631","https://openalex.org/W2790522557"],"abstract_inverted_index":{"Abstract":[0],"AIMS":[1],"To":[2],"review":[3,38],"the":[4,189,198,203],"data":[5,160],"of":[6,18,39,45,78,129,165,178,200,250],"patients":[7,40,68],"in":[8,131,136,202,253],"NHS":[9],"Tayside":[10],"who":[11],"survived":[12,71],">24":[13,72],"months":[14,73,84],"from":[15],"a":[16,42,161,174,212,244],"diagnosis":[17,44,97],"GBM,":[19],"identifying":[20,48],"trends":[21],"in:":[22],"(i)":[23],"fixed":[24],"demographic":[25],"features;":[26],"(ii)":[27],"genetic":[28],"mutations;":[29],"(iii)":[30],"treatment":[31,63],"pathways.":[32],"METHOD":[33],"A":[34],"retrospective":[35],"case":[36],"note":[37],"with":[41,50,231],"new":[43],"GBM":[46,204],"2015-2020,":[47],"those":[49],">2":[51],"year":[52,75,163,176],"survival.":[53,216],"Data":[54],"analysed:":[55],"demographics":[56],"(gender,":[57],"age),":[58],"mutations":[59],"(IDH1,":[60],"MGMT),":[61],"and":[62,122,219,226],"(surgical,":[64],"chemotherapy/radiotherapy).":[65],"RESULTS":[66],"84":[67],"identified.":[69],"18":[70,88],"(2":[74],"survival":[76,81,164,177],"rate":[77],"21.4%).":[79],"Median":[80,94],"=":[82,92],"31":[83],"(range":[85,99],"24-110":[86],"months);":[87],"patients:":[89],"M:F":[90],"ratio":[91],"1.6:1;":[93],"age":[95],"at":[96],"54.5":[98],"34-72":[100],"years);":[101],"13":[102],"methylated":[103],"MGMT,":[104],"2":[105,109,149,162,175,192],"unmethylated":[106],"(3":[107],"unknown);":[108,115],"mutated":[110],"IDH1,":[111],"10":[112],"wildtype":[113],"(6":[114],"16":[116],"maximum":[117],"surgical":[118,221],"resection;":[119],"17":[120,125],"chemoradiation":[121,225],"adjuvant":[123,227],"chemotherapy;":[124],"received":[126,134],"radiation":[127],"dose":[128],"60Gy":[130],"30#,":[132],"1":[133],"40Gy":[135],"15#;":[137],"11":[138],"had":[139,146],"disease":[140],"progression":[141],"requiring":[142],"further":[143,155,241],"treatment;":[144],"5":[145],"no":[147],"progression,":[148],"progressed":[150],"but":[151,186,206],"did":[152],"not":[153,187,211],"have":[154],"treatment.":[156],"CONCLUSION":[157],"In":[158,169],"Stupp":[159],"26.5%":[166],"was":[167,184],"reached.":[168],"our":[170,235],"real":[171],"world":[172],"cohort,":[173],"21.4%":[179],"is":[180,210,237],"satisfactory.":[181],"MGMT":[182],"methylation":[183],"common,":[185],"exclusively":[188],"case.":[190],"Only":[191],"were":[193],"IDH1":[194],"mutated,":[195],"possibly":[196],"reflecting":[197],"frequency":[199],"occurrence":[201],"population,":[205],"demonstrating":[207],"that":[208],"it":[209],"prerequisite":[213],"for":[214],"improved":[215,232],"Younger":[217],"age,":[218],"maximal":[220],"resection":[222],"followed":[223],"by":[224],"chemotherapy":[228],"are":[229],"associated":[230],"prognosis.":[233],"Recognising":[234],"dataset":[236],"small,":[238],"we":[239],"recommend":[240],"studies":[242],"using":[243],"larger":[245],"cohort":[246],"to":[247],"improve":[248],"understanding":[249],"better":[251],"outcomes":[252],"this":[254],"patient":[255],"group.":[256]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-10-02T00:00:00"}